Classifier | Cancer class | Precision | Recall | F1-score |
---|---|---|---|---|
(a) Performance metrics for KNN | ||||
KNN | High-grade serous ovarian cancer | 0.56 | 0.61 | 0.59 |
Human diffuse type gastric cancer | 0.88 | 0.71 | 0.79 | |
Intrahepatic cholangiocarcinoma | 0.79 | 0.85 | 0.82 | |
Non BRCA1/BRCA2 familial breast cancer | 0.82 | 0.96 | 0.89 | |
Pancreatic adenocarcinoma | 0.60 | 0.62 | 0.61 | |
Weighted accuracy | Â | 0.77 | Â | Â |
(b) Performance metrics for SVM | ||||
SVM | High-grade serous ovarian cancer | 0.66 | 0.58 | 0.62 |
Human diffuse type gastric cancer | 0.83 | 0.66 | 0.73 | |
Intrahepatic cholangiocarcinoma | 0.85 | 0.86 | 0.86 | |
Non BRCA1/BRCA2 familial breast cancer | 0.84 | 0.99 | 0.91 | |
Pancreatic adenocarcinoma | 0.62 | 0.71 | 0.66 | |
Weighted accuracy | Â | 0.76 | Â | Â |
(c) Performance metrics for neural networks | ||||
Neural networks | High-grade serous ovarian cancer | 0.75 | 0.74 | 0.74 |
Human diffuse type gastric cancer | 0.83 | 0.78 | 0.80 | |
Intrahepatic cholangiocarcinoma | 0.85 | 0.89 | 0.87 | |
Non BRCA1/BRCA2 familial breast cancer | 0.89 | 0.92 | 0.91 | |
Pancreatic adenocarcinoma | 0.78 | 0.78 | 0.78 | |
Weighted accuracy | Â | 0.82 | Â | Â |
(d) Performance metrics for ensemble model | ||||
Ensemble model | High-grade serous ovarian cancer | 0.76 | 0.78 | 0.77 |
Human diffuse type gastric cancer | 0.82 | 0.77 | 0.79 | |
Intrahepatic cholangiocarcinoma | 0.84 | 0.91 | 0.87 | |
Non BRCA1/BRCA2 familial breast cancer | 0.89 | 0.93 | 0.91 | |
Pancreatic adenocarcinoma | 0.83 | 0.77 | 0.80 | |
Weighted accuracy | Â | 0.82 | Â | Â |